Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

411 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A preliminary trial of lamivudine for chronic hepatitis B infection.
Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. Dienstag JL, et al. Among authors: schiff er. N Engl J Med. 1995 Dec 21;333(25):1657-61. doi: 10.1056/NEJM199512213332501. N Engl J Med. 1995. PMID: 7477217 Free article. Clinical Trial.
Lamivudine as initial treatment for chronic hepatitis B in the United States.
Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann HW, Goodman Z, Crowther L, Condreay LD, Woessner M, Rubin M, Brown NA. Dienstag JL, et al. Among authors: schiff er. N Engl J Med. 1999 Oct 21;341(17):1256-63. doi: 10.1056/NEJM199910213411702. N Engl J Med. 1999. PMID: 10528035 Free article. Clinical Trial.
A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.
Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC Jr, Lindsay K, Payne J, Dienstag JL, O'Brien C, Tamburro C, Jacobson IM, Sampliner R, Feit D, Lefkowitch J, Kuhns M, Meschievitz C, Sanghvi B, Albrecht J, Gibas A; Hepatitis Interventional Therapy Group. Perrillo RP, et al. Among authors: schiff er. N Engl J Med. 1990 Aug 2;323(5):295-301. doi: 10.1056/NEJM199008023230503. N Engl J Med. 1990. PMID: 2195346 Free article. Clinical Trial.
Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B.
Perrillo RP, Lai CL, Liaw YF, Dienstag JL, Schiff ER, Schalm SW, Heathcote EJ, Brown NA, Atkins M, Woessner M, Gardner SD. Perrillo RP, et al. Among authors: schiff er. Hepatology. 2002 Jul;36(1):186-94. doi: 10.1053/jhep.2002.34294. Hepatology. 2002. PMID: 12085364 Clinical Trial.
Histological outcome during long-term lamivudine therapy.
Dienstag JL, Goldin RD, Heathcote EJ, Hann HW, Woessner M, Stephenson SL, Gardner S, Gray DF, Schiff ER. Dienstag JL, et al. Among authors: schiff er. Gastroenterology. 2003 Jan;124(1):105-17. doi: 10.1053/gast.2003.50013. Gastroenterology. 2003. PMID: 12512035 Clinical Trial.
Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders.
Schiff ER, Dienstag JL, Karayalcin S, Grimm IS, Perrillo RP, Husa P, de Man RA, Goodman Z, Condreay LD, Crowther LM, Woessner MA, McPhillips PJ, Brown NA; International Lamivudine Investigator Group. Schiff ER, et al. J Hepatol. 2003 Jun;38(6):818-26. doi: 10.1016/s0168-8278(03)00076-x. J Hepatol. 2003. PMID: 12763376 Clinical Trial.
A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.
Perrillo RP, Wright T, Rakela J, Levy G, Schiff E, Gish R, Martin P, Dienstag J, Adams P, Dickson R, Anschuetz G, Bell S, Condreay L, Brown N; Lamivudine North American Transplant Group. Perrillo RP, et al. Hepatology. 2001 Feb;33(2):424-32. doi: 10.1053/jhep.2001.21554. Hepatology. 2001. PMID: 11172345 Clinical Trial.
411 results